S. Campana
About
In The Last Decade
S. Campana
18 papers receiving 353 citations
Peers
Comparison fields: 5 of 72
- Pulmonary and Respiratory Medicine 215
- Molecular Biology 126
- Molecular Medicine 98
- Epidemiology 57
- Infectious Diseases 38
Countries citing papers authored by S. Campana
This map shows the geographic impact of S. Campana's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Campana with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Campana more than expected).
Fields of papers citing papers by S. Campana
This network shows the impact of papers produced by S. Campana. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Campana. The network helps show where S. Campana may publish in the future.
Co-authorship network of co-authors of S. Campana
This figure shows the co-authorship network connecting the top 25 collaborators of S. Campana. A scholar is included among the top collaborators of S. Campana based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Campana. S. Campana is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 7 | |
| 3 | 65 | |
| 4 | 1 | |
| 5 | 1 | |
| 6 | 10 | |
| 7 | 26 | |
| 8 | 13 | |
| 9 | 17 | |
| 10 | 6 | |
| 11 | 7 | |
| 12 | 28 | |
| 13 | Early eradication therapy against Pseudomonas aeruginosa in cystic fibrosis | 6 |
| 14 | 142 | |
| 15 | 23 | |
| 16 | 5 | |
| 17 | [Anti-Pseudomonas aeruginosa antibodies, circulating immune complexes, and anticytoplasm antibodies of neutrophils in patients with cystic fibrosis with and without Pseudomonas aeruginosa colonization]. | 3 |
| 18 | [Use of quinolones in the treatment of Pseudomonas aeruginosa infections in children with cystic fibrosis]. | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.